Back to Tom Steyer
Tom Steyer → EXEL via FARALLON CAPITAL MANAGEMENT, L.L.C.
Tom Steyer EXEL Position History
Exelixis, Inc. • Healthcare
Quarters held
15
Latest value
$732.8M
Q2 2026
Peak value
$831.9M
First seen
Q2 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $732.8M | 13.47M | — | — |
| Q1 2026 | $562.3M | 13.11M | — | — |
| Q4 2025 | $688.5M | 15.71M | — | — |
| Q3 2025 | $805.4M | 19.50M | — | — |
| Q3 2025 | $805.4M | 19.50M | — | — |
| Q2 2025 | $706.8M | 16.04M | — | — |
| Q1 2025 | $831.9M | 22.53M | — | — |
| Q4 2024 | $780.5M | 23.44M | — | — |
| Q3 2024 | $659.4M | 25.41M | — | — |
| Q2 2024 | $609M | 27.10M | — | — |
| Q1 2024 | $633.1M | 26.68M | — | — |
| Q1 2024 | $633.1M | 26.68M | — | — |
| Q4 2023 | $639M | 26.63M | — | — |
| Q3 2023 | $565M | 25.86M | — | — |
| Q2 2023 | $494.2M | 25.86M | — | — |